Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
(WorldNews France)

December 10, 2018 -New York (N.Y.)- Cellectis(Euronext Growth: ALCLS - Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the appointment of William (Bill) Monteith to the role of Senior Vice President U.S. Manufacturing. This appointment follows Cellectis` plan to establish commercial manufacturing capabilities in the U.S., which will be Bill Monteith`s...